Armata Pharmaceuticals, Inc. (ARMP) Stock

Armata Pharmaceuticals, Inc. (ARMP) is a Healthcare stock trading at $7.01 (as of 2026-06-18), with a market capitalization of $297.08M and a trailing P/E of -0.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company developing targeted bacteriophage therapeutics for antibiotic-resistant infections. Its pipeline includes bacteriophage candidates for Staphylococcus aureus bacteremia and Pseudomonas aeruginosa infections, and it also has a partnership with Merck & Co. for developing synthetic bacteriophage candidates.

Valuation — source: SEC EDGAR (first-party)
Price	$7.01
Market Cap	$297.08M
P/E Ratio	-0.9
EV / EBITDA	0.2
Price / Book	-0.00
DCF Value (model)	$-11.84
DCF Upside vs Price	-268.8%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$179000.00
Net Margin	-38572.6%
Return on Equity	90.7%
Current Ratio	0.64

Valuation vs Sector & Industry
Stock P/E	-0.9
Sector P/E (Healthcare)	20.9
Industry P/E (Pharmaceutical Products)	17.0
vs Sector	-104.4%
vs Industry	-105.3%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	Madison Asset Management, LLC ($21.58M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Deborah L. Birx
Employees	60
Country	US
IPO Date	1994-05-20

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.